Reflector Bio
Biotechnology · Drug Discovery
Overview
In silico phenotypic screening. Structure-based tools miss cellular context and off-target effects. Reflector Bio predicts how your molecules perform in secondary and cell-based assays, for earlier go/no-go decisions.
Funding and backers
Backers
1
Techstars
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
We believe every clinical trial should be run twice — first in silico. InSilicoTrials · Est.
KumiChem is DLeader's agentic AI platform for RNA drug discovery — ASO and siRNA design, in silico toxicity screening, and data-driven…
AI-powered in silico toxicology platform for drug discovery. Predict mutagenicity, hERG, DILI, ADME and 55+ models from SMILES…
Discover how our cutting-edge measurement technology accelerates drug discovery by unlocking the structure of complex molecules and…
PharmEnable combines medicinal chemistry expertise with machine learning to find drug candidates for challenging protein targets. Founded…
To find the right drug for the right target…. Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
TechstarsVia a fund
4363 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York
United States
HQ